Sunday, December 07, 2025 | 07:16 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Nifty Pharma index hits 5-year low; Glenmark at 7-year low post Q1 results

Glenmark Pharmaceuticals plunged 9 per cent, while Dr Reddy's slipped 8 per cent in intra-day trade

Growth in the US market was the reason for the overall revenue rise of many companies
premium

SI Reporter Mumbai
Shares of pharmaceutical companies were under pressure during the morning trade on Wednesday with Nifty Pharma index hitting a 5-year low of 7,550, down nearly 4 per cent on the NSE. The pharma index fell below its previous low of 7,602 touched on June 6, 2014.

Among individual stocks, Glenmark Pharmaceuticals plunged 9 per cent intra-day to Rs 380 apiece, hitting an over 7-year low after its June quarter result missed analysts' expectations. The stock was quoting at its lowest level since August 2, 2012.

The pharma company reported a consolidated net profit at Rs 109 crore in Q1FY20 as